Effectiveness and Safety of Cladribine in Relapsing-Remitting Multiple Sclerosis in Clinical Practice: A 2-Year Multicenter Retrospective Open-Label Study.
Fortes-González SM, Herrero-Poch L, Pato-Pato A, Soto J G-de, Multiple Sclerosis Study Group of the Galician Society of Neurology
Ann Indian Acad Neurol. 2026 May 22. PMID: 42172148.Abstract
